Source:http://linkedlifedata.com/resource/pubmed/id/20933308
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
12
|
pubmed:dateCreated |
2010-11-24
|
pubmed:abstractText |
The biological importance of microtubules in mitosis, as well as in interphase, makes them an interesting target for the development of anticancer agents. Small molecules such as benzo[b]thiophenes are attractive as inhibitors of tubulin polymerization. Thus, a new class of compounds that incorporated the structural motif of the 2-(3',4',5'-trimethoxybenzoyl)-3-aryl/arylamino benzo[b]thiophene molecular skeleton, with electron-donating (Me, OMe, SMe or OEt) or electron-withdrawing (F and Cl) substituents on the B-ring, was synthesized and evaluated for antiproliferative activity, inhibition of tubulin polymerization and cell cycle effects. The most promising compound in this series was 2-(3',4',5'-trimethoxybenzoyl)-3-(4'-ethoxyphenyl)-benzo[b]thiophene (4e), which significantly inhibited cancer cell growth at submicromolar concentrations, especially against HeLa and Jurkat cells, and interacted with tubulin. As determined by flow cytometric analysis, 4e caused G2/M phase arrest and apoptosis in a time- and concentration-dependent manner. The block in G2/M was correlated with increased expression of cyclin B1 and phosphorylation of cdc25c. Moreover, 4e perturbed mitochondrial membrane potential and caused activation of caspase-3 and cleavage of poly(ADP-rybose)polymerase (PARP), events that are involved in 4e-induced apoptosis.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1768-3254
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright © 2010 Elsevier Masson SAS. All rights reserved.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
45
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
5781-91
|
pubmed:dateRevised |
2011-4-13
|
pubmed:meshHeading |
pubmed-meshheading:20933308-Antineoplastic Agents,
pubmed-meshheading:20933308-Caspase 3,
pubmed-meshheading:20933308-Cell Cycle,
pubmed-meshheading:20933308-Cell Death,
pubmed-meshheading:20933308-Cell Line, Tumor,
pubmed-meshheading:20933308-Cell Proliferation,
pubmed-meshheading:20933308-Dose-Response Relationship, Drug,
pubmed-meshheading:20933308-Drug Screening Assays, Antitumor,
pubmed-meshheading:20933308-HeLa Cells,
pubmed-meshheading:20933308-Humans,
pubmed-meshheading:20933308-Jurkat Cells,
pubmed-meshheading:20933308-Molecular Structure,
pubmed-meshheading:20933308-Stereoisomerism,
pubmed-meshheading:20933308-Structure-Activity Relationship,
pubmed-meshheading:20933308-Thiophenes,
pubmed-meshheading:20933308-Tubulin
|
pubmed:year |
2010
|
pubmed:articleTitle |
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agents.
|
pubmed:affiliation |
Dipartimento di Scienze Farmaceutiche, Università di Ferrara, Via Fossato di Mortara 17-19, 44100 Ferrara, Italy. rmr@unife.it
|
pubmed:publicationType |
Journal Article
|